Synopsys Treasury Stock decreased by 51.8% to $191.85M in Q4 2025 compared to the prior quarter. Year-over-year, this metric declined by 77.7%, from $860.97M to $191.85M. Over 4 years (FY 2021 to FY 2025), Treasury Stock shows a downward trend with a -15.5% CAGR.
An increase indicates active share buybacks, which can signal management's confidence in the stock or an effort to return capital to shareholders.
Treasury stock represents the cost of shares that a company has repurchased from the open market and holds in its own tr...
Standard across all public companies; peers in the pharmaceutical sector often use buybacks to manage earnings per share.
treasury_stock| Q3 '21 | Q3 '22 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $782.87M | $1.27B | $1.68B | $1.54B | $1.32B | $1.19B | $1.03B | $860.97M | $689.00M | $572.09M | $398.28M | $191.85M |
| QoQ Change | — | +62.6% | +31.6% | -8.1% | -14.1% | -10.1% | -13.7% | -16.1% | -20.0% | -17.0% | -30.4% | -51.8% |
| YoY Change | — | +62.6% | +31.6% | — | — | — | -38.8% | -44.1% | -47.9% | -51.9% | -61.2% | -77.7% |